Cargando…

Safety Assessment of the Pharmacotherapy Process at the Nurse and Midwife Level – An Observational Study

PURPOSE: Pharmacological errors are among the most common in the healthcare system. This study aimed to determine the level of safety of the pharmacotherapy process at the stage performed by nurses and midwives by indicating the key risk factors affecting patients’ safety. METHODS: A group of 1276 n...

Descripción completa

Detalles Bibliográficos
Autores principales: Witczak, Izabela, Uchmanowicz, Izabella, Tartaglia, Riccardo, Rypicz, Łukasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649244/
https://www.ncbi.nlm.nih.gov/pubmed/33177830
http://dx.doi.org/10.2147/TCRM.S276901
_version_ 1783607283785138176
author Witczak, Izabela
Uchmanowicz, Izabella
Tartaglia, Riccardo
Rypicz, Łukasz
author_facet Witczak, Izabela
Uchmanowicz, Izabella
Tartaglia, Riccardo
Rypicz, Łukasz
author_sort Witczak, Izabela
collection PubMed
description PURPOSE: Pharmacological errors are among the most common in the healthcare system. This study aimed to determine the level of safety of the pharmacotherapy process at the stage performed by nurses and midwives by indicating the key risk factors affecting patients’ safety. METHODS: A group of 1276 nurses and 136 midwives in Poland participated in the study. The survey was conducted in the period from May 2019 to August 2019. The original Nursing Risk in Pharmacotherapy (NURIPH) tool was used. RESULTS: The Cronbach alpha coefficient was 0.832. The low legibility of the medical orders (item 1) was indicated as the highest risk. A mean of 4.50 means that this factor’s significance is assessed between “very significant” and “significant.” The communication between physician, nurse and midwife, time pressure, and work organization were also rated high (Items 2, 3, and 4). The averages for these factors are higher than 4, so their evaluation is more than “significant.”. CONCLUSION: Nurses and midwives involved in the pharmacotherapy process are exposed to many ergonomic factors triggering risk. A huge problem is the lack of readability of medical orders, which may be a factor triggering a medical error.
format Online
Article
Text
id pubmed-7649244
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-76492442020-11-10 Safety Assessment of the Pharmacotherapy Process at the Nurse and Midwife Level – An Observational Study Witczak, Izabela Uchmanowicz, Izabella Tartaglia, Riccardo Rypicz, Łukasz Ther Clin Risk Manag Original Research PURPOSE: Pharmacological errors are among the most common in the healthcare system. This study aimed to determine the level of safety of the pharmacotherapy process at the stage performed by nurses and midwives by indicating the key risk factors affecting patients’ safety. METHODS: A group of 1276 nurses and 136 midwives in Poland participated in the study. The survey was conducted in the period from May 2019 to August 2019. The original Nursing Risk in Pharmacotherapy (NURIPH) tool was used. RESULTS: The Cronbach alpha coefficient was 0.832. The low legibility of the medical orders (item 1) was indicated as the highest risk. A mean of 4.50 means that this factor’s significance is assessed between “very significant” and “significant.” The communication between physician, nurse and midwife, time pressure, and work organization were also rated high (Items 2, 3, and 4). The averages for these factors are higher than 4, so their evaluation is more than “significant.”. CONCLUSION: Nurses and midwives involved in the pharmacotherapy process are exposed to many ergonomic factors triggering risk. A huge problem is the lack of readability of medical orders, which may be a factor triggering a medical error. Dove 2020-11-04 /pmc/articles/PMC7649244/ /pubmed/33177830 http://dx.doi.org/10.2147/TCRM.S276901 Text en © 2020 Witczak et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Witczak, Izabela
Uchmanowicz, Izabella
Tartaglia, Riccardo
Rypicz, Łukasz
Safety Assessment of the Pharmacotherapy Process at the Nurse and Midwife Level – An Observational Study
title Safety Assessment of the Pharmacotherapy Process at the Nurse and Midwife Level – An Observational Study
title_full Safety Assessment of the Pharmacotherapy Process at the Nurse and Midwife Level – An Observational Study
title_fullStr Safety Assessment of the Pharmacotherapy Process at the Nurse and Midwife Level – An Observational Study
title_full_unstemmed Safety Assessment of the Pharmacotherapy Process at the Nurse and Midwife Level – An Observational Study
title_short Safety Assessment of the Pharmacotherapy Process at the Nurse and Midwife Level – An Observational Study
title_sort safety assessment of the pharmacotherapy process at the nurse and midwife level – an observational study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649244/
https://www.ncbi.nlm.nih.gov/pubmed/33177830
http://dx.doi.org/10.2147/TCRM.S276901
work_keys_str_mv AT witczakizabela safetyassessmentofthepharmacotherapyprocessatthenurseandmidwifelevelanobservationalstudy
AT uchmanowiczizabella safetyassessmentofthepharmacotherapyprocessatthenurseandmidwifelevelanobservationalstudy
AT tartagliariccardo safetyassessmentofthepharmacotherapyprocessatthenurseandmidwifelevelanobservationalstudy
AT rypiczłukasz safetyassessmentofthepharmacotherapyprocessatthenurseandmidwifelevelanobservationalstudy